Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd., a foreign private issuer, on February 8, 2019. The filing incorporates by reference a press release dated February 8, 2019, announcing the pricing of a public offering.
Key Financial Metrics
The filing discloses the pricing of a public offering totaling $6.5 million. The document does not provide specific figures for revenue, profit, cash flow, operating margins, existing debt levels, or liquidity ratios as of the reporting date.
Material Changes
The primary material event reported is the initiation of a $6.5 million public offering. No comparative financial data or changes in operational metrics versus prior periods are included in this specific filing.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the offering pricing. The filing does not contain updated financial guidance, specific risk factors, contingencies, or details regarding unusual items beyond the capital raise itself.
Investor Verification Checklist
- Verify the final closing date and net proceeds of the $6.5 million public offering.
- Confirm the intended use of proceeds from the capital raise.
- Review the company's most recent audited financial statements (Form 20-F) for current liquidity and debt positions, as this 6-K does not provide them.
- Check for any subsequent filings regarding the completion of the offering.